Dr Antoine Hollebecque
- Specialty
- Oncologist, colon, stomach, liver and pancreas expert
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. (Jun 7, 2025)
- Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers. (Jun 3, 2025)
- Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials. (Jun 1, 2025)
- Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]. (Apr 30, 2025)
- Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma. (Jan 1, 2025)